0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Microbiology (non-medical) > Virology

Not currently available

Case for Interferon - How a 1980s Cancer Drug Might Be the Wonder Therapy for the Twenty-First Century (Hardcover) Loot Price: R578
Discovery Miles 5 780
You Save: R121 (17%)
Case for Interferon - How a 1980s Cancer Drug Might Be the Wonder Therapy for the Twenty-First Century (Hardcover): Joseph...

Case for Interferon - How a 1980s Cancer Drug Might Be the Wonder Therapy for the Twenty-First Century (Hardcover)

Joseph Cummins, Kent Heckenlively; Foreword by Judy Mikovits

 (sign in to rate)
List price R699 Loot Price R578 Discovery Miles 5 780 You Save R121 (17%)

Bookmark and Share

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

Touted as a potential breakthrough cancer therapy in the 1980s by the scientific community and publications such as TIME and Newsweek magazine, the reputation of interferon has not lived up to its early promise. Interferons are small proteins with anti-viral and anti-cancer effects, which have the power to modulate the functioning of the immune system. But Dr. Joseph Cummins, an early interferon pioneer, holder of sixteen US medical patents, author of more than sixty scientific publications, as well as having taught veterinary medicine at the University of Missouri, University of Illinois, and Texas A & M University, argues that the current thinking on interferon is fundamentally flawed. Interferon is created in small quantities in the body in response to infection, and seems to work best at these low dosages. However, the public health cowboys, working under the assumption that anything good in tiny amounts must be better in massive amounts, pursued exactly the wrong strategy. High-dose interferon does not work in the body and may even cause problems. The first remarkable results for interferon and the flu were reported by the Soviets in the 1970s, but Western medicine discounted these findings because they believed the dosages were so low they couldn't possibly be effective. In the 1980s, when interferon was expensive to produce and only small quantities could be manufactured, the results were remarkable. Dr. Cummins was an early pioneer of low-dose interferon, and his remarkable findings among animals led to collaborations with medical doctors for human trials, even going so far as Africa at the height of the HIV-AIDS epidemic. Cummins reviews the evidence for this inexpensive, safe treatment and makes an eloquent argument for medical science to take another look at interferon to tackle today's most challenging health conditions, including COVID-19.

General

Imprint: Sky Pony Press
Country of origin: United States
Release date: 2021
Authors: Joseph Cummins • Kent Heckenlively
Foreword by: Judy Mikovits
Dimensions: 228 x 152mm (L x W)
Format: Hardcover - Cloth over boards
Pages: 200
ISBN-13: 978-1-5107-6550-4
Categories: Books > Science & Mathematics > Biology, life sciences > Microbiology (non-medical) > Virology
LSN: 1-5107-6550-6
Barcode: 9781510765504

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners